Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

IVD Registration in 2026: IVDR Classification, CE Marking and Global Market Access

IVD registration under the EU IVDR demands more than paperwork. Discover how risk classification, performance evaluation, CE marking, and EUDAMED requirements shape market access, and learn the essential steps to avoid costly regulatory delays and certification setbacks.
  • Blog, Medical Devices
Laboratory testing equipment, blood samples, and digital regulatory documents illustrating IVD CE marking, performance evaluation, and European market access.

Medical Device Registration in Brazil in 2026: ANVISA Classification, Notification, Registration and Market Authorization

Learn how ANVISA classifies medical devices, when notification or registration applies, and what manufacturers need for BGMP, local representation, technical documentation, and market access. This guide helps teams avoid common submission delays and plan a clearer regulatory pathway in Brazil.
  • Blog, Medical Devices
Medical device and regulatory dossier with a Brazil map illustrating Brazil medical device regulations, ANVISA review, and compliance workflow.

Medical Device Registration in Saudi Arabia in 2026: SFDA Approval, MDMA Requirements, Classification and Market Access

Entering Saudi Arabia’s medical device market requires more than submitting an application. Explore SFDA classification, MDMA registration, authorized representative licensing, QMS evidence, inspection findings, and post-market obligations to understand what manufacturers need for compliant market access.
  • Blog, Medical Devices
Karte von Saudi-Arabien mit Medizintechnik, regulatorischen Dokumenten und einem digitalen Workflow für die MDMA-Registrierung.

Medical Device Registration in Korea in 2026: MFDS Approval, Classification, Technical Documentation and KGMP Requirements

Entering South Korea’s medical device market requires more than a product dossier. Explore how risk classification, regulatory documentation, local representation, and quality-system requirements shape the approval pathway—and learn which steps can help prevent avoidable submission delays.
  • Blog, Medical Devices
South Korean flag and Seoul skyline alongside medical devices, the MFDS headquarters, and regulatory documents illustrating MFDS medical device registration requirements.

Medical Device Registration in Singapore in 2026: HSA Requirements, Risk Classification, Evaluation Routes and Approval Process

Planning medical device registration in Singapore? Discover how HSA risk classes, evaluation routes, ASEAN CSDT requirements, and dealer licences shape approval. Read our practical guide to avoid delays and understand your post-market responsibilities before entering the Singapore market.
  • Blog, Medical Devices
Medical devices, regulatory documents, and a digital approval workflow overlooking Singapore’s skyline, illustrating HSA evaluation routes and compliance requirements.

Medical Device Registration in China in 2026: NMPA Classification, Approval Process, Clinical Evaluation and Compliance

Medical device registration in China requires careful planning from classification to approval. Discover how NMPA rules shape clinical evaluation, type testing, local agent responsibilities, and GMP compliance, plus practical steps to prevent registration delays and maintain compliance after launch.
  • Blog, Medical Devices
Medical monitoring device, technical dossier, and China map illustrating NMPA approval, type testing, and regulatory compliance.

CDSCO Medical Device Registration in 2026: Classification, Licensing, Approval and Compliance Requirements

Navigating medical device registration in India requires accurate risk classification, licensing documentation, and inspection readiness. Explore CDSCO requirements under the Medical Devices Rules 2017, including manufacturing approvals, import licensing, quality management obligations, and common compliance challenges manufacturers must address.
  • Blog, Medical Devices
Regulatory affairs professional reviewing medical device registration in India on a tablet, with medical equipment, compliance documentation, and digital approval workflow icons.

Pharma QMS Software in 2026: GMP Selection Checklist for CAPA, Deviations and Validation

Choosing an eQMS involves more than features and price. Discover how pharmaceutical QA teams can assess deviation management, CAPA effectiveness, audit trails, validation, and vendor evidence to select a system that supports GMP compliance and inspection readiness.
  • Blog, Computerized System Validation
Quality assurance specialist using a tablet in a pharmaceutical cleanroom, with digital icons representing document control, audit trail review, approvals, and deviation management.

LIMS Software in Pharma in 2026: A GMP Guide to Validation and Data Integrity

Can your QC laboratory trace every result from sample registration to final approval? Learn how GMP LIMS supports data integrity, what inspectors check, and how risk-based LIMS validation helps keep pharmaceutical laboratories inspection-ready throughout the system lifecycle.
  • Blog, Computerized System Validation
Two pharmaceutical QC scientists reviewing a digital laboratory workflow with sample tracking, chromatogram results, and approval controls, illustrating GMP LIMS data integrity.

Pharma Software Solutions in 2026: GxP-Compliant Systems for Quality, Manufacturing & Validation

Choosing pharma software solutions involves more than checking features. Learn how to assess eQMS, LIMS, and MES systems, evaluate suppliers, manage GxP risks, and maintain validated, inspection-ready operations under evolving GMP and data integrity requirements.
  • Blog, Computerized System Validation
Pharmaceutical quality specialist reviewing digital dashboards for data integrity, eQMS, LIMS, and GMP manufacturing in a modern pharmaceutical facility.